 |
| Artificial Retina |
Researchers in the US have created the first Artificial Retina, a remarkably thin device built of 2D materials that may restore vision to those who have retinal degenerative diseases. Millions of patients with conditions including macular degeneration and diabetic retinopathy may benefit from the technique, it is believed. Disorders affecting the retina, the layer of tissue at the back of the eye, are referred to as retinal disorders. Nerve cells in the retina gather visual data and transmit it to the brain. When retinal diseases are not addressed, they can lead to major eye problems, including blindness. Although implants are now undergoing clinical studies, there are worries that, due to their rigidity, they could lead to long-term strain on the eye.
Researchers in the US have created the first Artificial Retina, a remarkably thin device built of 2D materials that may restore vision to those who have retinal degenerative diseases. Millions of patients with conditions including macular degeneration and diabetic retinopathy may benefit from the technique, it is believed. Disorders affecting the retina, the layer of tissue at the back of the eye, are referred to as retinal disorders. Nerve cells in the retina gather visual data and transmit it to the brain. When retinal diseases are not addressed, they can lead to major eye problems, including blindness. Scientists believe the artificial retina could be a crucial milestone in the development of Artificial Retina because tests have demonstrated that it successfully resembles the structure and properties of the human eye. Patients with advanced RP who are 25 years of age or older may use the Argus II.
Patients with retinitis pimentos who have poor vision or an impression of naked
light should use it. Patients with Argus II cannot have additional conditions
like glaucoma that harm the optic nerve, nor can they use glaucoma medications
right now, nor can they have had retinal detachments in the past. It makes no
difference if they had cataracts or an intraocular lens; the majority of the
study's participants did.